Answers are grounded in this paper and cite their sources.
Review synthesizes multimodal foundation models enhancing colorectal cancer prognosis, suggesting pathways for clinical application.
Colorectal cancer (CRC) is characterized by profound, multi-layered heterogeneity that limits the precision of conventional single-modality clinical tools. The emergence of multimodal foundation models (MFMs) represents a conceptual paradigm shift, moving beyond static biomarkers to capture the dynamic and evolving nature of CRC. MFMs integrate histopathology, radiology, multi-omics data (including the critical regulatory layer of epigenomics), and clinical variables into shared high-dimensional representational spaces. This integration enables improved prognostication, refined molecular subtyping, and in silico simulation of therapeutic perturbations within the tumor’s functional landscape, thereby supporting rational and model-driven drug development. In this review, we synthesize the rapidly expanding body of CRC-specific MFM research and critically examine the unresolved challenges that currently limit clinical translation. We place particular emphasis on the transition from correlation to causal inference, the establishment of cross-population generalizability, and the resolution of key issues related to trustworthiness and clinical interpretability. Finally, we propose an actionable roadmap outlining regulatory, data governance, and translational requirements, including the lab-in-the-loop paradigm, necessary to position MFMs as a robust and equitable framework in clinical oncology.
No takes yet. Share an insight, caveat, or question.
Amirabadi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: